Literature DB >> 16785589

The role of ubiquitous airborne fungi in chronic rhinosinusitis.

Jens U Ponikau1, David A Sherris, Gail M Kephart, Cheryl Adolphson, Hirohito Kita.   

Abstract

Chronic rhinosinusitis (CRS) is a confusing disease for both allergists and otorhinolaryngologists, partly because of its poorly understood pathophysiology and partly because of its limited treatment options. Several recent reports have provided evidence for a better understanding of the etiology and the relationship of CRS to airborne fungi-especially to Alternaria. First, the development of novel methods enables detection of certain fungi in mucus from the nasal and paranasal sinus cavities. Second, a non-IgE-mediated immunological mechanism for reactivity of patients with CRS to certain common fungi has been described. Third, these fungi are surrounded by eosinophils in vivo, suggesting that they are targeted by eosinophils. Finally, the preliminary results of studies using antifungal agents to treat patients with CRS are promising. Overall, these recent discoveries provide a logical mechanism for the pathophysiology of CRS, and they also suggest promising avenues for treatment of CRS with antifungal agents.

Entities:  

Mesh:

Year:  2006        PMID: 16785589     DOI: 10.1385/CRIAI:30:3:187

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  38 in total

1.  Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study.

Authors:  A E Stoop; H A van der Heijden; J Biewenga; S van der Baan
Journal:  J Allergy Clin Immunol       Date:  1993-02       Impact factor: 10.793

2.  Validity of a new health-related quality of life instrument for patients with chronic sinusitis.

Authors:  Steven J Atlas; Ralph B Metson; Daniel E Singer; Yen A Wu; Richard E Gliklich
Journal:  Laryngoscope       Date:  2005-05       Impact factor: 3.325

3.  Treatment of allergic fungal sinusitis with high-dose itraconazole.

Authors:  B Manrin Rains; Corey W Mineck
Journal:  Am J Rhinol       Date:  2003 Jan-Feb

4.  Chronic rhinosinusitis: is the nose really involved?

Authors:  N Bhattacharyya
Journal:  Am J Rhinol       Date:  2001 May-Jun

5.  Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial.

Authors:  Jens U Ponikau; David A Sherris; Amy Weaver; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

6.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

7.  Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein.

Authors:  Matthew J Taylor; Jens U Ponikau; David A Sherris; Eugene B Kern; Thomas A Gaffey; Gail Kephart; Hirohito Kita
Journal:  Otolaryngol Head Neck Surg       Date:  2002-11       Impact factor: 3.497

8.  GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP).

Authors:  D L Hamilos; D Y Leung; D P Huston; A Kamil; R Wood; Q Hamid
Journal:  Clin Exp Allergy       Date:  1998-09       Impact factor: 5.018

9.  Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma?

Authors:  Jens U Ponikau; David A Sherris; Gail M Kephart; Eugene B Kern; Thomas A Gaffey; James E Tarara; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

10.  Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis.

Authors:  D L Hamilos; D Y Leung; R Wood; L Cunningham; D K Bean; Z Yasruel; E Schotman; Q Hamid
Journal:  J Allergy Clin Immunol       Date:  1995-10       Impact factor: 10.793

View more
  10 in total

1.  Vasculitis: current status and future directions.

Authors:  Pierre Youinou
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Cutting edge issues in autoimmunity.

Authors:  Yaniv Sherer; Torsten Matthias; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

3.  Ethmoid sinus mycology of chronic rhinosinusitis.

Authors:  R S Jiang; K L Liang; J Y Shiao; J F Lin; M C Su; C H Hsin; F J Lu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-09       Impact factor: 3.267

Review 4.  Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis.

Authors:  David D Tieu; Robert C Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

Review 5.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis.

Authors:  Angela L Nocera; Sarina K Mueller; Alan D Workman; Dawei Wu; Kristen McDonnell; Peter M Sadow; Mansoor M Amiji; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-05-31       Impact factor: 14.290

7.  Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3.

Authors:  Kota Wada; Takao Kobayashi; Yoshinori Matsuwaki; Hiroshi Moriyama; Hirohito Kita
Journal:  Int Arch Allergy Immunol       Date:  2013-05-29       Impact factor: 2.749

8.  Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b.

Authors:  Juhan Yoon; Jens U Ponikau; Christopher B Lawrence; Hirohito Kita
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Antifungal treatment and chronic rhinosinusitis.

Authors:  Devyani Lal; James A Stankiewicz
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

Review 10.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.